in tachycardic chest pain patients: a risk for hypotension or not? Prehosp Emerg Care. 2017; 21(1):68–73.39 39 Meine TJ, Roe MT, Chen AY, et al. Association of intravenous morphine use and outcomes in acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative. Am Heart J. 2005; 149(6):1043–9.
40 40 Koh JQS, Fernando H, Peter K, Stub D. Opioids and ST elevation myocardial infarction: a systematic review. Heart Lung Circ. 2019; 28:697–706.
41 41 Antman EM, Hand M, Armstrong PW, et al. 2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients with ST‐Elevation Myocardial Infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians: 2007 Writing Group to Review New Evidence and Update the ACC/AHA 2004 Guidelines for the Management of Patients with ST‐Elevation Myocardial Infarction, writing on behalf of the 2004 Writing Committee. Circulation. 2008; 117:296–329.
42 42 Weldon ER, Ariano RE, Grierson RA. Comparison of fentanyl and morphine in the prehospital treatment of ischemic type chest pain. Prehosp Emerg Care. 2016; 20(1):45–51.
43 43 Chen ZM, Pan HC, Chen YP, et al. Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo‐controlled trial. Lance. 2005; 366(9497):1622–32.
44 44 Weaver WD, Cerqueira M, Hallstrom AP, et al. Prehospital‐initiated vs hospital‐initiated thrombolytic therapy. The Myocardial Infarction Triage and Intervention Trial. JAMA. 1993; 270:1211–6.
45 45 The European Myocardial Infarction Project Group. Prehospital thrombolytic therapy in patients with suspected acute myocardial infarction. N Engl J Med. 1993; 329:383–9.
46 46 Morrison LJ, Verbeek PR, McDonald AC, Sawadsky BV, Cook DJ. Mortality and prehospital thrombolysis for acute myocardial infarction: a meta‐analysis. JAMA. 2000; 283:2686–92.
47 47 Savino PB, Sporer KA, Barger JA, et al. Chest pain of suspected cardiac origin: current evidence‐based recommendations for prehospital care. West J Emerg Med. 2015; 16:983–95.
48 48 Stenestrand U, Lindback J, Wallentin L. Long‐term outcome of primary percutaneous coronary intervention vs prehospital and in‐hospital thrombolysis for patients with ST‐elevation myocardial infarction. JAMA. 2006; 296:1749–56.
49 49 Widimsky P, Budesinsky T, Vorac D, et al. Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction. Final results of the randomized national multicentre trial‐‐PRAGUE‐2. Eur Heart J. 2003; 24:94–104.
50 50 Busk M, Maeng M, Rasmussen K, et al. The Danish multicentre randomized study of fibrinolytic therapy vs. primary angioplasty in acute myocardial infarction (the DANAMI‐2 trial): outcome after 3 years follow‐up. Eur Heart J. 2008; 29:1259–66.
51 51 Swor R, Anderson W, Jackson R, Wilson A. Effects of EMS transportation on time to diagnosis and treatment of acute myocardial infarction in the emergency department. Prehosp Disaster Med. 1994; 9:160–4.
52 52 Luepker RV, Raczynski JM, Osganian S, et al. Effect of a community intervention on patient delay and emergency medical service use in acute coronary heart disease: The Rapid Early Action for Coronary Treatment (REACT) Trial. JAMA. 2000; 284:60–7.
53 53 McNamara RL, Wang Y, Herrin J, et al. Effect of door‐to‐balloon time on mortality in patients with ST‐segment elevation myocardial infarction. J Am Coll Cardiol. 2006; 47:2180–6.
54 54 Brown JP, Mahmud E, Dunford JV, Ben‐Yehuda O. Effect of prehospital 12‐lead electrocardiogram on activation of the cardiac catheterization laboratory and door‐to‐balloon time in ST‐segment elevation acute myocardial infarction. Am J Cardiol. 2008; 101:158–61.
55 55 Bradley EH, Herrin J, Wang Y, et al. Strategies for reducing the door‐to‐balloon time in acute myocardial infarction. N Engl J Med. 2006; 355:2308–20.
56 56 Larson DM, Menssen KM, Sharkey SW, et al. “False‐positive” cardiac catheterization laboratory activation among patients with suspected ST‐segment elevation myocardial infarction. JAMA. 2007; 298:2754–60.
57 57 Youngquist ST, Kaji AH, Lipsky AM, Koenig WJ, Niemann JT. A Bayesian sensitivity analysis of out‐of‐hospital 12‐lead electrocardiograms: implications for regionalization of cardiac care. Acad Emerg Med. 2007; 14:1165–71.
58 58 Nestler DM, White RD, Rihal CS, et al. Impact of prehospital electrocardiogram protocol and immediate catheterization team activation for patients with ST‐elevation‐myocardial infarction. Circ Cardiovasc Qual Outcomes. 2011; 4:640–6.
59 59 Cone DC, Lee CH, Van Gelder C. EMS activation of the cardiac catheterization laboratory is associated with process improvements in the care of myocardial infarction patients. Prehosp Emerg Care. 2013; 17:293–8.
60 60 Horvath SA, Xu K, Nwanyanwu F, et al. Impact of the prehospital activation strategy in patients with ST‐elevation myocardial infarction undergoing primary percutaneous revascularization: a single center community hospital experience. Crit Pathw Cardiol. 2012; 11:186–92.
61 61 Shavadia JS, Roe MT, Chen AY, et al. Association between cardiac catheterization laboratory pre‐activation and reperfusion timing metrics and outcomes in patients with ST‐segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a report from the ACTION registry. JACC Cardiovasc Interv. 2018; 11:1837–47.
62 62 Osganian SK, Zapka JG, Feldman HA, et al. Use of emergency medical services for suspected acute cardiac ischemia among demographic and clinical patient subgroups: the REACT trial. Rapid Early Action for Coronary Treatment. Prehosp Emerg Care. 2002; 6:175–85.
63 63 Nallamothu BK, Bates ER, Wang Y, Bradley EH, Krumholz HM. Driving times and distances to hospitals with percutaneous coronary intervention in the United States: implications for prehospital triage of patients with ST‐elevation myocardial infarction. Circulation. 2006; 113:1189–95.
64 64 Green JL, Jacobs AK, Holmes D, et al. Taking the reins on systems of care for ST‐segment‐elevation myocardial infarction patients: A report from the American Heart Association Mission: Lifeline Program. Circ Cardiovasc Interv. 2018; 11:e005706.
65 65 Le May MR, So DY, Dionne R, et al. A citywide protocol for primary PCI in ST‐segment elevation myocardial infarction. N Engl J Med. 2008; 358:231–40.
66 66 van't Hof AW, Rasoul S, van de Wetering H, et al. Feasibility and benefit of prehospital diagnosis, triage, and therapy by paramedics only in patients who are candidates for primary angioplasty for acute myocardial infarction. Am Heart J. 2006; 151:1255 e1–5.
67 67 Dorsch MF, Greenwood JP, Priestley C, et al. Direct ambulance admission to the cardiac catheterization laboratory significantly reduces door‐to‐balloon times in primary percutaneous coronary intervention. Am Heart J. 2008; 155:1054–8.
68 68 Henry TD, Sharkey SW, Burke MN, et al. A regional system to provide timely access to percutaneous coronary intervention for ST‐elevation myocardial infarction. Circulation. 2007; 116:721–8.
69 69 Ting HH, Rihal CS, Gersh BJ, et al. Regional systems of care to optimize timeliness of reperfusion therapy for ST‐elevation myocardial infarction: the Mayo Clinic STEMI Protocol. Circulation. 2007; 116:729–36.
70 70 Thomas SH, Kociszewski C, Hyde RJ, Brennan PJ, Wedel SK. Prehospital electrocardiogram
